Literature DB >> 31393519

Accelerating the Science of SCD Therapies-Is a Cure Possible?

Edward J Benz1, Traci Heath Mondoro2, Gary H Gibbons2.   

Abstract

Entities:  

Year:  2019        PMID： 31393519     DOI： 10.1001/jama.2019.11419

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.

Authors:  C Byrnes; M Botello-Harbaum; T Clemons; L Bailey; K M Valdes; V H Coleman-Cowger
Journal:  J Natl Med Assoc       Date:  2022-01-31       Impact factor: 1.798

2.  5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.

Authors:  Scott Hansen; David K Wood; John M Higgins
Journal:  Br J Haematol       Date:  2019-12-30       Impact factor: 6.998

3.  The molecular basis for the prothrombotic state in sickle cell disease.

Authors:  Arun S Shet; Maria A Lizarralde-Iragorri; Rakhi P Naik
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

4.  Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.

Authors:  Hae Lin Cho; Scott Y H Kim; Courtney Fitzhugh; Matthew Hsieh; John Tisdale; Christine Grady
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-19       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.